Obesity is strongly associated with insulin resistance and an increased risk of type 2 diabetes, the ARC-treated HFD mice showed improved insulin sensitivity (Fig. 1M) and better tolerance to a glucose load (Fig. 1K and L). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.